AFT Pharmaceuticals raises $9.1M via redeemable share issue, announces SPP

Rebecca Howard
Thu, 16 Mar 2017

By Rebecca Howard March 17 (BusinessDesk) -  AFT Pharmaceuticals, which manufactures the Maxigesic painkiller, raised new funds through a redeemable share issue to fuel international growth and announced plans to raise more capital in a share purchase plan. The Auckland-based drug maker said the redeemable share issue raised approximately $9.1 million from CRG, a US health-care investor, and the Atkinson Family Trust at $2.74 per share, equal to the volume weighted average price of AFT's ordinary shares on the NZX over the last five busin...
Primary Sector
$25m for Milford tunnel as Southland gets pre-election funding
Brent Melville | Thu, 16 Jul 2020

The Homer Tunnel, a transport lifeline into and out of Milford Sound, Fiordland, will receive a $25 million upgrade as part of a swathe of pre-election government investment into Southland that also i...

Cheaper petrol, accommodation through lockdown tames inflation
Paul McBeth | Thu, 16 Jul 2020

Cheaper petrol and accommodation slowed the annual pace of inflation through the covid-19 lockdown, more than offsetting price spikes in other consumer goods. The consumers price index shrank 0.5 p...

Delegat profits up 37%
Victoria Young | Thu, 16 Jul 2020

Wine maker Delegat Group's unaudited profit after tax for the year to June 30 rose 37 percent to $64.1 million, the company reported. The figure includes fair value movements in its vines and deriv...